Cargando…
A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia
BACKGROUND: Hepcidin plays a central role in iron homeostasis and erythropoiesis. Neutralizing hepcidin with a monoclonal antibody (mAb) may prevent ferroportin internalization, restore iron efflux from cells, and allow transferrin-mediated iron transport to the bone marrow. This multicenter, phase...
Autores principales: | Vadhan-Raj, Saroj, Abonour, Rafat, Goldman, Jonathan W., Smith, David A., Slapak, Christopher A., Ilaria, Robert L., Tiu, Ramon V., Wang, Xuejing, Callies, Sophie, Cox, Joanne, Tuttle, Jay L., Lau, Yiu-Keung, Roeland, Eric J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361694/ https://www.ncbi.nlm.nih.gov/pubmed/28327200 http://dx.doi.org/10.1186/s13045-017-0427-x |
Ejemplares similares
-
Hepcidin and sports anemia
por: Kong, Wei-Na, et al.
Publicado: (2014) -
Iron, anemia and hepcidin in malaria
por: Spottiswoode, Natasha, et al.
Publicado: (2014) -
Role of hepcidin in the pathophysiology and diagnosis of anemia
por: D'Angelo, Guido
Publicado: (2013) -
Hepcidin and Anemia: A Tight Relationship
por: Pagani, Alessia, et al.
Publicado: (2019) -
Effect of Interleukin and Hepcidin in Anemia of Chronic Diseases
por: Yacoub, Maha F., et al.
Publicado: (2020)